Brain Barrier Virtual Meeting

The seventh Cold Spring Harbor conference on Brain Barriers is going virtual and will begin with a late morning session on Wednesday, April 7 and conclude late afternoon on Friday, April 9, 2021.

The purpose of this Cold Spring Harbor meeting is to explore and encourage new conceptual approaches and to apply novel methods to the neuroprotective physiologies of BBB structures. Our goal is pair genetic model organism biological methods with recent insights in vertebrate BBB physiology and development. We hope to create cross fertilization between fields that rarely see each other and get people thinking about how model systems can help parse the regulatory networks necessary for parsimonious BBB function.

The conference is intended to foster cross-disciplinary exchange of ideas and expertise between developmental and evolutionary biologists, vascular and BBB physiologists and disease oriented industry scientists interested in modifying or circumventing specific pathways of neuroprotection. While a number of speakers have been invited, please note that the majority of oral presentations will be drawn from openly submitted abstracts. The abstract deadline is January 29, 2021.

Dritan Agalliu, Columbia University
Maria Lehtinen, Boston Children’s Hospital
Benoit Vanhollebeke, Universite Libre de Bruxelles, Belgium

Emerging Concepts and Hot Topics in CNS Barriers
Imaging Approaches to Study CNS Barriers
Development, Plasticity and Specialization of CNS Barriers
Systems, Computational and Cell Biology of the CNS Barriers
Neuroimmune Interactions Across CNS Barriers
CNS Barriers in Aging, Senescence and Neurodegeneration

Panel Discussion: “The brilliance barrier Stereotypes about brilliance are an obstacle to diversity in science and beyond”.

Workshop: “How to frame and write constructive, fair peer-review”

For more information, visit the Brain Barriers meeting website.

Hydrocephalus Society Global Webinar Series on iNPH

The Hydrocephalus Society Board of Directors has developed a virtual scientific and educational programme, consisting of six free of charge webinars, dealing with idiopathic Normal Pressure Hydrocephalus (iNPH) to provide hydrocephalus-related training opportunities.

Part 1 of the Global Webinar Series begins on November 20, 2020!

For our first topic “Clinical work-up” we are pleased to announce 3 distinguished speakers:

  • When should we suspect iNPH? (Intro, epidemiology) by Mark Hamilton
  • Which are the typical clinical symptoms? The clinical syndrome of iNPH: gait & balance, cognition, urinary by Giorgio Palandri
  • The typical radiological picture. CT, MR by Karin Kockum

We hope to see you all there and stay tuned for all our upcoming and exciting webinars!

Download the programme outline for the Global Webinar Series here!

Register for Part 1 to here!

Newborn Screening Summit: Sept. 8-10

NBSTRN is excited to host the Newborn Screening (NBS) Virtual Summit to celebrate newborn screening awareness month in September.

Attend the online summit on Sept 8-10, 2020 from 9 am to 12 pm (PST).

The event is free, but you must register at Once you registered, you will receive a separate email with the Zoom information to attend the virtual summit.

Here is the fantastic line-up of speakers on the latest newborn screening research.

Speaker Line-up (in PST time zone):

Sept 8, 2020

  • 9 am – Dr. Curt Scharfe, Machine Learning in NBS
  • 10 am – Dr. Tracy Trotter, Hearing Differences
  • 11 am – Terri Klein, Advocacy and NBS

Sept 9, 2020

  • 9 am – Dr. Jennifer Kwon, Spinal Muscular Atrophy
  • 10 am – Dr. Wendy Chung, Congenital Heart Disease
  • 11 am – Dr. Ronald Wapner and Jessica Giordano, Prenatal Genetics

Sept 10, 2020

  • 9 am – John Boyle, Alissa Huston, Lynn Albizo, Advocacy, and NBS
  • 10 am – Kim Piper, Community Engagement
  • 11 am – Dr. Michele Puryear, Sickle Cell Diseases

Each speaker will speak for 30-minutes, following a 15-minutes live-chat messaging session with attendees. The summit will take place online virtually using the Zoom meeting platform.

Be informed. Be transformed with new research.

To learn more about newborn screening research, visit

This project has been funded in whole or in part with Federal funds from the NICHD, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN275201800005C.


A Virtual Experimental Biology in 2021

Given the ongoing COVID-19 pandemic, Experimental Biology has been forced to cancel our in-person meeting in Indianapolis, Indiana, May 1-4, 2021. However, we will offer Experimental Biology in a virtual format, which means that you and your colleagues will have many new and exciting opportunities for scientific discovery without travel.

Our new virtual meeting will bring you the latest research in anatomy, biochemistry, molecular biology, investigative pathology, pharmacology, and physiology. The 2021 dates will be announced soon.

What will our new virtual conference look like? Well, that’s up to you!

Please take five minutes to complete this brief survey by August 14, 2020. Your input will make Experimental Biology 2021 a creative and stimulating meeting that delivers the outstanding scientific content you expect.

As a thank-you for sharing your ideas, you can enter into a drawing for a $100 Amazon gift card.

Database Update!

Our databases page has been updated and a new database has been published! Find below descriptions of the information available in each database:

  • Prevalence: Prevalence and incidence rates for different etiologies of hydrocephalus among different populations.
  • Comorbidities: Prevalence of a variety of comorbid conditions among different etiologies of hydrocephalus.
  • Genetics: Known genetic causes of hydrocephalus in both humans and animals.
  • Animal Models – Kaolin: Information on different methodologies and models for inducing hydrocephalus in animals via kaolin injection.
  • Animal Models – Blood Products [NEW]: Information on different methodologies and models for inducing hydrocephalus via injection of various blood products.

All these databases are also downloadable. If you have any papers you would like added to a database, please send them to:

Grant Opportunity: 2020 Innovator Awards

The Hydrocephalus Association requests applications for:


Innovator Award Research Focus:

Goal:  To provide seed funding for high-quality, innovative research that potentially improves hydrocephalus treatments and outcomes or changes our understanding of hydrocephalus.

Project Focus: Identifying new mechanisms responsible for the development of the hydrocephalus.

Identifying or testing new therapeutic targets.

Preclinical or clinical testing of new drug therapies and other treatments.

Emphasis will be placed on innovation and potential impact of the project on hydrocephalus research and clinical outcomes. Investigators studying any etiology of hydrocephalus are invited to submit a letter of intent (LOI). There are no restrictions on the age of onset, type, or stage of hydrocephalus that can be studied.

This award will support research in the following areas:

  • hydrocephalus pathogenesis and secondary injury mechanisms (e.g. cellular, molecular, signaling, developmental, and genetic mechanisms).
  • drug target identification.
  • preclinical drug development and testing.
  • preclinical non-surgical interventions.
  • preclinical or clinical medical device testing.*
  • new clinical treatments or interventions. *

*All applicants intending to include human subjects must indicate this in the LOI and will be contacted to determine whether the project falls within the scope of this RFA.

This award will not support:

  • incremental progress of an established research program or project.
  • minor modifications to current treatment approaches.
  • development of new animal, in vivo, or in vitro models (See NIH PA-18-623 for funding opportunities in this area).
  • imaging studies (intervention studies using imaging as an outcome measure are allowed).
  • development or testing of intracranial pressure monitors.
  • development of tools to aid in clinical decision making.
  • development or modification of tools to advance hydrocephalus research (See NIH PA-18-623 for funding opportunities in this area).
  • business plan development.
  • projects with commercial development partners (i.e., participation of for-profit corporation(s)).

Award Details:

This award provides short term seed funding (up to 12 months).

  • The project must be designed to be completed within the 12-month timeline.
  • Proposals must be submitted for actual costs at one of two funding levels, $25,000 or $50,000.
  • Total funding for this award cycle is expected to be $200,000.
  • Preliminary data is not required.
  • The award provides no institutional overhead.

For more information go to: